President and CEO

Chief Technology Officer

From Clinic to Couch: How In-Home Neuromodulation Could Change TMS, Depression Care

Neurostim Pain Devices Market to Reach USD 25,477.3 Million by 2035, Driven by Innovation in Chronic Pain Therapy

Neuronetics management to meet virtually with Piper Sandler

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Cash Posting Specialist

Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. They are seeking a Payment Poster to manage daily cash posting and reconciliation of payments, ensuring accuracy and timeliness in the revenue cycle.

Sign up with Google

Sign in with Google